Urte Gayko
Corporate Officer/Principal en SUMMIT THERAPEUTICS INC. .
Perfil
Urte Gayko is currently the Director & Head of Regulatory Affairs at Summit Therapeutics Ltd.
and the Chief Regulatory & Pharmacovigilance Officer at Summit Therapeutics, Inc. She previously worked as the Director of Regulatory Affairs at Amgen, Inc. from 1999 to 2008.
She also held positions as the Senior VP of Drug Development & Regulatory Affairs at Nektar Therapeutics, Vice President of Global Regulatory Affairs at Pharmacyclics LLC in 2012, and Vice President of Regulatory & Clinical Affairs at Nodality, Inc. from 2008 to 2012.
Dr. Gayko obtained a doctorate degree from Harvard University and completed her undergraduate and graduate studies at Freie Universität Berlin.
Cargos activos de Urte Gayko
| Empresas | Cargo | Inicio |
|---|---|---|
| SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | 16/10/2023 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Urte Gayko.
| Empresas | Cargo | Fin |
|---|---|---|
| NEKTAR THERAPEUTICS | Consejero General | 01/05/2022 |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2012 |
| AMGEN INC. | Consejero General | 01/01/2008 |
| PHARMACYCLICS, INC. | Consejero General | - |
Formación de Urte Gayko.
| Freie Universität Berlin | Graduate Degree |
| Harvard University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| SUMMIT THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Urte Gayko
